• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

钆螯合物在肾源性系统性纤维化机制中的作用:最新进展

Involvement of gadolinium chelates in the mechanism of nephrogenic systemic fibrosis: an update.

作者信息

Idée Jean-Marc, Port Marc, Dencausse Anne, Lancelot Eric, Corot Claire

机构信息

Guerbet, Research Division, BP 57400, 95943 Roissy Charles de Gaulle cedex, France.

出版信息

Radiol Clin North Am. 2009 Sep;47(5):855-69, vii. doi: 10.1016/j.rcl.2009.06.006.

DOI:10.1016/j.rcl.2009.06.006
PMID:19744600
Abstract

Nephrogenic systemic fibrosis (NSF) is a highly debilitating scleroderma-like disease occurring exclusively in patients with severe or end-stage renal failure. Since the recognition of a link between gadolinium chelates (GCs) used as contrast agents for MR imaging and NSF by two independent European teams in 2006, numerous studies have described the clinical issues and investigated the mechanism of this disease. So far the most commonly reported hypothesis is based on the in vivo dechelation of GCs. The physicochemical properties of GCs, especially their thermodynamic and kinetic stabilities, are described in the present article. High kinetic stability provided by the macrocyclic structure, combined with high thermodynamic stability, minimizes the amount of free gadolinium released in the body. The current hypotheses regarding the pathophysiologic mechanism are critically discussed.

摘要

肾源性系统性纤维化(NSF)是一种极具致残性的硬皮病样疾病,仅发生于严重或终末期肾衰竭患者。自2006年两个独立的欧洲研究团队发现用于磁共振成像的钆螯合物(GCs)与NSF之间存在关联以来,众多研究描述了该疾病的临床问题并对其发病机制进行了研究。迄今为止,最常报道的假说是基于GCs在体内的脱螯作用。本文描述了GCs的物理化学性质,尤其是它们的热力学和动力学稳定性。大环结构提供的高动力学稳定性,再加上高热力学稳定性,使体内释放的游离钆量降至最低。本文对目前关于病理生理机制的假说进行了批判性讨论。

相似文献

1
Involvement of gadolinium chelates in the mechanism of nephrogenic systemic fibrosis: an update.钆螯合物在肾源性系统性纤维化机制中的作用:最新进展
Radiol Clin North Am. 2009 Sep;47(5):855-69, vii. doi: 10.1016/j.rcl.2009.06.006.
2
Efficiency, thermodynamic and kinetic stability of marketed gadolinium chelates and their possible clinical consequences: a critical review.市售钆螯合物的效率、热力学和动力学稳定性及其可能的临床后果:一项批判性综述。
Biometals. 2008 Aug;21(4):469-90. doi: 10.1007/s10534-008-9135-x. Epub 2008 Mar 15.
3
Possible involvement of gadolinium chelates in the pathophysiology of nephrogenic systemic fibrosis: a critical review.钆螯合物在肾源性系统性纤维化病理生理学中的可能作用:一项批判性综述
Toxicology. 2008 Jun 27;248(2-3):77-88. doi: 10.1016/j.tox.2008.03.012. Epub 2008 Mar 22.
4
Role of thermodynamic and kinetic parameters in gadolinium chelate stability.热力学和动力学参数在钆螯合物稳定性中的作用。
J Magn Reson Imaging. 2009 Dec;30(6):1249-58. doi: 10.1002/jmri.21967.
5
Nephrogenic systemic fibrosis.肾源性系统性纤维化
Magn Reson Imaging Clin N Am. 2009 Feb;17(1):159-67. doi: 10.1016/j.mric.2009.01.003.
6
The role of gadolinium chelates in the mechanism of nephrogenic systemic fibrosis: A critical update.钆螯合物在肾源性系统性纤维化发病机制中的作用:关键性更新。
Crit Rev Toxicol. 2014 Nov;44(10):895-913. doi: 10.3109/10408444.2014.955568. Epub 2014 Sep 26.
7
Gadolinium-associated nephrogenic systemic fibrosis.钆相关的肾源性系统性纤维化。
Am Fam Physician. 2009 Oct 1;80(7):711-4.
8
Gadolinium-based contrast agents and nephrogenic systemic fibrosis: why did it happen and what have we learned?基于钆的对比剂与肾源性系统性纤维化:它为何发生以及我们从中得到哪些教训?
J Magn Reson Imaging. 2009 Dec;30(6):1236-9. doi: 10.1002/jmri.21979.
9
Nephrogenic systemic fibrosis and its impact on abdominal imaging.肾源性系统性纤维化及其对腹部成像的影响。
Radiographics. 2009 Oct;29(6):1565-74. doi: 10.1148/rg.296095517.
10
Nephrogenic systemic fibrosis: more questions and some answers.肾源性系统性纤维化:更多问题与一些答案
Nephron Clin Pract. 2008;110(1):c24-31; discussion c32. doi: 10.1159/000151228. Epub 2008 Aug 7.

引用本文的文献

1
The Emergence of Nanotechnology in the Prognosis and Treatment of Myocardial Infarctions.纳米技术在心肌梗死预后及治疗中的出现。
Recent Pat Nanotechnol. 2025;19(1):35-55. doi: 10.2174/1872210517666230721123453.
2
Nanocomposites of Nitrogen-Doped Graphene Oxide and Manganese Oxide for Photodynamic Therapy and Magnetic Resonance Imaging.氮掺杂氧化石墨烯/氧化锰纳米复合材料用于光动力学治疗和磁共振成像。
Int J Mol Sci. 2022 Dec 1;23(23):15087. doi: 10.3390/ijms232315087.
3
GMBP1-conjugated manganese oxide nanoplates for monitoring of gastric cancer MDR using magnetic resonance imaging.
用于磁共振成像监测胃癌多药耐药的GMBP1共轭氧化锰纳米片
RSC Adv. 2020 Apr 3;10(23):13687-13695. doi: 10.1039/d0ra00897d. eCollection 2020 Apr 1.
4
The Effect of Magnetic Field Gradient and Gadolinium-Based MRI Contrast Agent Dotarem on Mouse Macrophages.磁场梯度和基于钆的 MRI 造影剂 Dotarem 对小鼠巨噬细胞的影响。
Cells. 2022 Feb 22;11(5):757. doi: 10.3390/cells11050757.
5
Advances in magnetic resonance imaging contrast agents for glioblastoma-targeting theranostics.用于胶质母细胞瘤靶向诊疗的磁共振成像造影剂的进展
Regen Biomater. 2021 Nov 12;8(6):rbab062. doi: 10.1093/rb/rbab062. eCollection 2021 Dec.
6
Manganese-Doped N-Hydroxyphthalimide-Derived Carbon Dots-Theranostics Applications in Experimental Breast Cancer Models.锰掺杂的N-羟基邻苯二甲酰亚胺衍生碳点在实验性乳腺癌模型中的诊疗应用。
Pharmaceutics. 2021 Nov 22;13(11):1982. doi: 10.3390/pharmaceutics13111982.
7
Manganese-Based Targeted Nanoparticles for Postoperative Gastric Cancer Monitoring Magnetic Resonance Imaging.用于术后胃癌监测的磁共振成像的锰基靶向纳米颗粒
Front Oncol. 2020 Oct 19;10:601538. doi: 10.3389/fonc.2020.601538. eCollection 2020.
8
Practical recommendations for the safe use of gadolinium in magnetic resonance imaging: a Delphi expert panel study.磁共振成像中钆安全使用的实用建议:一项德尔菲专家小组研究。
Radiol Bras. 2020 Jul-Aug;53(4):216-222. doi: 10.1590/0100-3984.2019.0074.
9
Retention of Gadolinium in Brain Parenchyma: Pathways for Speciation, Access, and Distribution. A Critical Review.钆在脑实质中的潴留:物种形成、进入和分布途径。一篇批判性综述。
J Magn Reson Imaging. 2020 Nov;52(5):1293-1305. doi: 10.1002/jmri.27124. Epub 2020 Apr 4.
10
Manganese Oxide Nanoparticles As MRI Contrast Agents In Tumor Multimodal Imaging And Therapy.锰氧化物纳米颗粒作为肿瘤多模态成像和治疗的 MRI 对比剂。
Int J Nanomedicine. 2019 Oct 21;14:8321-8344. doi: 10.2147/IJN.S218085. eCollection 2019.